Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2023 08:02 ET | Source: MiMedx Group, Inc

MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates

Fourth quarter and full year 2022 net sales expected in the ranges of $73 million to $76 million and $266 million to $269 million, respectively Provides commentary regarding the potential impact of...
January 04, 2023 16:01 ET | Source: MiMedx Group, Inc

MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED

MIMEDX aligns with a leading distributor of wound care products in Japan to capitalize on first-mover advantage for EPIFIX MARIETTA, Ga. and OSAKA, Japan, Jan. 04, 2023 (GLOBE NEWSWIRE) -- MiMedx...
January 03, 2023 08:00 ET | Source: MiMedx Group, Inc

MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer

MIMEDX bolsters management team with 30+ year MedTech veteran with extensive operational leadership MARIETTA, Ga., Jan. 03, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or...
December 08, 2022 08:00 ET | Source: MiMedx Group, Inc

MIMEDX Announces Wound & Surgical Product Pipeline Expansion via In-Licensing and Distribution Agreement with Turn Therapeutics

Agreement provides MIMEDX with exclusive rights to Turn’s PermaFusion® proprietary antimicrobial intellectual property (IP), accelerating the product development pipeline for wound and surgical...
November 10, 2022 08:00 ET | Source: MiMedx Group, Inc

MIMEDX to Present at Upcoming Investor Conferences

MARIETTA, Ga., Nov. 10, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that senior management...
November 02, 2022 16:15 ET | Source: MiMedx Group, Inc

MIMEDX Announces Third Quarter 2022 Operating and Financial Results

Third Quarter Net Sales of $67.7 Million Reflect Growth of 7.3% Introducing Wound & Surgical and Regenerative Medicine Segment Reporting to Highlight Trends Within Each Business Unit Third...
October 19, 2022 08:00 ET | Source: MiMedx Group, Inc

MIMEDX to Host Third Quarter 2022 Operating and Financial Results Conference Call on November 2

MARIETTA, Ga., Oct. 19, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that it will report...
October 04, 2022 08:00 ET | Source: MiMedx Group, Inc

MIMEDX Appoints Matt Notarianni as Head of Investor Relations

Experienced Healthcare-focused Financial and Communications Leader to Strengthen and Expand Relationships with Investment Community MARIETTA, Ga., Oct. 04, 2022 (GLOBE NEWSWIRE) -- MiMedx Group,...
September 20, 2022 08:00 ET | Source: MiMedx Group, Inc

MIMEDX Announces Launch of AXIOFILL™

Adds a Unique Collagen Matrix Particulate Derived from Human-Placental Tissue to the Growing $1B Surgical Recovery Market MARIETTA, Ga., Sept. 20, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc....
September 19, 2022 07:00 ET | Source: MiMedx Group, Inc

MIMEDX Announces Launch of AMNIOEFFECT™

New Product Enables Company to Target Additional Surgical Procedures and Deepen Market Penetration in the Growing $1B Surgical Recovery Market MARIETTA, Ga., Sept. 19, 2022 (GLOBE NEWSWIRE) --...